FDA OKs Pfizer drug for rare type of leukemia
By Linda A. Johnson
The Associated Press
BUSINESS
TRENTON, N.J. » The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed.
The agency approved Pfizer Inc.’s Besponsa for patients with a type of advanced...
Read latest New Haven Register (New Haven, CT) online.
Online newspapers
at PressDisplay.